Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03229551 · ClinicalTrials.gov registry record · Phase 2
Xylitol for Chronic Sinusitis
A Phase 2 study, sponsored by Ochsner Health System.
- Completed
- Registry status
- Phase 2
- Development phase
- 1
- Enrollment target
NCT03229551 is a Phase 2 study that has completed, run by Ochsner Health System. The registered enrollment target is 1 participants.
The verdict
NCT03229551, a Phase 2 study, has completed, sponsored by Ochsner Health System.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1 participants
- Enrollment target
Study Summary
The purpose of this investigation is to conduct a randomized controlled trial within a subgroup of difficult-to-treat patients with CRS, evaluating the use of topical xylitol treatment concurrently with topical steroid/antibiotics combination in the effort to disrupt biofilms and improve disease control. The effectiveness of topical surfactants is a research gap in treating CRS but has promising correlates in other medical fields. Specifically, the investigators will be studying the effect of topical xylitol therapy on biofilm production with the use of PCR bacterial sequencing before and after medical intervention.
Interventions
- DRUG Saline
- DRUG Xylitol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2018-07-16 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03229551
The ClinicalTrials.gov registry entry for NCT03229551 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ochsner Health System, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT03229551 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03229551 about?
NCT03229551 is a clinical study titled "Xylitol for Chronic Sinusitis". The purpose of this investigation is to conduct a randomized controlled trial within a subgroup of difficult-to-treat patients with CRS, evaluating the use of topical xylitol treatment concurrently with topical steroid/antibiotics combination in the effort to disrupt biofilms and improve disease con...
What is the current status of trial NCT03229551?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1 participants. The study started on 2018-03-01. Estimated completion is 2018-07-16.
What interventions are being tested in trial NCT03229551?
The interventions under investigation include: Saline (DRUG), Xylitol (DRUG).
Who is sponsoring clinical trial NCT03229551?
This trial is sponsored by Ochsner Health System, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.